News of Note—Altimmune’s new CEO, Scripps’ HIV vaccine and more

newspaper
(Pixabay)

Here is some other vaccine news of note for the week:

> Altimmune has poached Neos Therapeutics’ CEO, Vipin Crag, Ph.D., to succeed Bill Enright as its president and CEO. Release

> Scripps Research scientists have found a way to stabilize HIV envelope protein for a new HIV vaccine. The candidate elicited robust anti-HIV antibody responses in mice and rabbits, the team reported. Release

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

> The NIH awarded Tulane University School of Medicine a contract worth up to $8.5 million to develop a more effective and longer-lasting vaccine against whooping cough. Release